BioSpace News Archive

Skye Bioscience, Inc. announced today that it will host a special virtual investor presentation on Tuesday, October 12.

InsightRX, which provides a cloud-based precision dosing platform to help guide treatment decisions, announced today that it will be participating with Saladax Biomedical, Inc., at the upcoming 19th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) from Sept. 19-22, 2021.

Nimble Therapeutics, a biotechnology company revolutionizing the discovery and development of peptide therapeutics, today announced their strategic research collaboration with Incyte (NASDAQ: INCY) has been expanded to include discovery of additional novel peptide therapies.

Cleveland Diagnostics, Inc., a commercial stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that Eric Klein, MD, Chairman of the Glickman Urological & Kidney Institute at Cleveland Clinic, delivered two presentations at the annual meeting of the American Urological Association regarding the company’s prostate cancer test, IsoPSA.

IntraBio Inc announced positive results from the full data set for its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis.

Therma Bright will commence trading on the OTCQB with the market open on September 14, 2021, under the symbol “TBRIF”.

Treated compassionately with ACP-01 for ischemic cardiomyopathy, dilated cardiomyopathy, chronic obstructive pulmonary disease and vascular dementia, each recipient of the ACP-01 treatment recounts in full detail their return to a quality of life they thought was lost forever.

T2 Biosystems, Inc. today announced it will unveil new data at industry conferences this month to showcase results and implications of the use of its rapid diagnostics technologies.

Centinel Spine ® today announced the first international implantation of the 3D-Printed Porous Titanium FLX ™ platform.

OmniLife, a communication and collaboration platform for the organ donation, transplantation, and research community, has initiated a research partnership with Loma Linda University (LLU) Transplant Institute to drive innovation around transplant graft selection and acceptance, specifically with the goal of reducing waitlist mortality.